Sector: Healthcare | Industry: Healthcare Facilities & Services |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 8480 E. Orchard Road, Suite 4900 GREENWOOD VILLAGE CO 80503 |
Tel: | 1-949-5743860 |
Website: | https://www.selectis.com |
IR: | See website |
Key People | ||
Adam Arthur Desmond Chief Executive Officer, Director | Jim Creamer Interim Chief Financial Officer |
Business Overview |
Selectis Health, Inc. acquires, develops, leases, manages, and disposes of healthcare real estate, provides financing to healthcare providers, and provides healthcare operations through its wholly owned subsidiaries. Its portfolio is comprised of investments in three healthcare segments: senior housing, including independent and assisted living; post-acute/skilled nursing facilities; and bonds securing senior housing communities. The Company owns and operates, through wholly owned subsidiaries, Assisted Living Facilities, Independent Living Facilities, and Skilled Nursing Facilities across the South and Southeastern portions of the United States. Assisted Living Facilities are licensed care facilities that provide personal care services, support, and housing for those who need help with activities of daily living yet require limited medical care. Independent Living Facilities are designed to meet the needs of seniors who choose to live in an environment surrounded by their peers. |
Financial Overview |
For the nine months ended 30 September 2023, Selectis Health Inc revenues decreased 7% to $27.6M. Net loss applicable to common stockholders increased 59% to $360K. Revenues reflect Healthcare Grant Revenue decrease of 44% to $1.6M, Healthcare Revenue decrease of 4% to $25.5M. Higher net loss reflects Property Taxes, Insurance, and Other opt increase of 12% to $23.6M (expense), General and Administrative increase of 41% to $7.5M (expense). |
Employees: | 655 as of Dec 31, 2022 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $41.83M as of Dec 31, 2023 |
Annual revenue (TTM): | $38.38M as of Dec 31, 2023 |
EBITDA (TTM): | -$5.72M as of Dec 31, 2023 |
Net annual income (TTM): | -$2.56M as of Dec 31, 2023 |
Free cash flow (TTM): | $2.80M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $34.95M as of Dec 31, 2023 |
Shares outstanding: | 3,067,059 as of Apr 6, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |